FDA Approves Three-Times-a-Week Copaxone (Glatiramer Acetate) for MS Patients

The FDA has approved three-times-a-week Copaxone 40 mg/mL for patients with relapsing forms of multiple sclerosis .

http://ift.tt/LoQYtu